dihydroergotamine has been researched along with Bleeding in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (65.38) | 18.7374 |
1990's | 9 (34.62) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kakkar, VV | 2 |
Gruber, UF | 1 |
Fredin, H; Gustafson, C; Rosberg, B | 1 |
Gratzl, O; Gruber, UF; Meisner, C; Rem, J | 1 |
Schott, G | 1 |
Aebi, B; Ammann, JF | 1 |
Raberger, G; Schwarz, M; Stanek, B; Zimpfer, M | 1 |
Baue, AE; Covey, TH | 1 |
Häring, R; Koppenhagen, K | 1 |
Breddin, HK; Kirchmaier, CM; Lindhoff-Last, E; Mosch, G; Rübesam, D; Scharrer, I; Vigh, Z; Wolf, H | 1 |
Arcelus, JI; Caprini, JA; Traverso, CI | 1 |
Gummerus, M; Halonen, P; Kaaja, R; Kajanoja, P; Lehtovirta, P; Partanen, S; Venesmaa, P | 1 |
al Butmeh, S; Dei-Anang, K; Hahn, K; Schwarz, M; Voth, D; Wolf, H | 1 |
Cade, JF; Gallus, AS; Mills, KW; Murphy, W | 1 |
Koppenhagen, K; Mälzer, H; Matthes, M; Weber, U | 1 |
Freick, H; Haas, S | 1 |
Brütsch, HP; Hoffman, R; Largiadèr, F | 1 |
Bergmann, H; Havlick, E; Hertz, H; Höfer, R; Kwasny, O; Maier, R; Orthner, E; Schemper, M; Wohlzogen, FX; Zekert, F | 1 |
Keller, K; Lüscher, T; Schreiner, WE; Steiner, RA | 1 |
Gratzl, O; Rem, JA; Reymond, MA | 1 |
Lindblad, B | 1 |
Beisaw, NE; Comerota, AJ; Diserio, FJ; Groth, HE; Merli, GJ; Sasahara, AA; Weitz, HH; Zimmerman, RC | 1 |
Buchhammer, T; Hamelmann, H; Hedderich, J; Köhler, A; Seifert, J; Voigt, J | 1 |
Bjerg-Nielsen, A; Christensen, SW; Duus, B; Hølmich, P; Wille-Jørgensen, P | 1 |
Comerota, AJ; White, JV | 1 |
6 review(s) available for dihydroergotamine and Bleeding
Article | Year |
---|---|
Prevention of venous thromboembolism.
Topics: Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Dextrans; Dihydroergotamine; Dipyridamole; Hemorrhage; Hemostasis; Heparin; Humans; Pulmonary Embolism; Thrombophlebitis | 1981 |
Low-dose heparin: an aid to therapy.
Topics: Aspirin; Clinical Trials as Topic; Dihydroergotamine; Double-Blind Method; Electric Stimulation; Hemorrhage; Heparin; Humans; Postoperative Complications; Prospective Studies; Pulmonary Embolism; Thromboembolism; Thrombophlebitis | 1980 |
Low-dose heparin - present status and future trends.
Topics: Clinical Trials as Topic; Dihydroergotamine; Drug Therapy, Combination; Forecasting; Hemorrhage; Heparin; Humans; Postoperative Complications; Pulmonary Embolism; Thrombophlebitis | 1980 |
Role of thromboelastography in evaluating other anticoagulant agents: warfarin and heparin-dihydroergotamine.
Topics: Adult; Aged; Animals; Anticoagulants; Blood Coagulation; Clinical Trials as Topic; Dihydroergotamine; Drug Combinations; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Middle Aged; Monitoring, Physiologic; Postoperative Complications; Prothrombin Time; Rabbits; Reference Standards; Thrombelastography; Thromboembolism; Warfarin | 1995 |
Apparent lack of synergism between heparin and dihydroergotamine in prevention of deep vein thrombosis after elective hip replacement: a randomised double-blind trial reported in conjunction with an overview of previous results.
Topics: Aged; Dihydroergotamine; Double-Blind Method; Drug Synergism; Female; Hemorrhage; Heparin; Hip Prosthesis; Humans; Male; Middle Aged; Prospective Studies; Thrombophlebitis | 1992 |
Prophylaxis of postoperative thromboembolism with low dose heparin alone or in combination with dihydroergotamine. A review.
Topics: Dihydroergotamine; Drug Therapy, Combination; Hemorrhage; Heparin; Humans; Postoperative Complications; Pulmonary Embolism; Thromboembolism; Thrombophlebitis | 1988 |
18 trial(s) available for dihydroergotamine and Bleeding
Article | Year |
---|---|
Prevention of fatal postoperative pulmonary embolism by heparin dihydroergotamine or Dextran 70.
Topics: Adolescent; Clinical Trials as Topic; Dextrans; Dihydroergotamine; Drug Combinations; Drug Hypersensitivity; Foot; Hematoma; Hemorrhage; Heparin; Hip; Humans; Intraoperative Complications; Leg; Postoperative Complications; Pulmonary Embolism; Random Allocation | 1982 |
Hypotensive anesthesia, thromboprophylaxis and postoperative thromboembolism in total hip arthroplasty.
Topics: Aged; Anesthesia, General; Dextrans; Dihydroergotamine; Drug Combinations; Female; Hematoma; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Hip Prosthesis; Humans; Hypotension, Controlled; Intraoperative Complications; Male; Middle Aged; Nitroprusside; Postoperative Complications; Premedication; Prospective Studies; Pulmonary Embolism; Thromboembolism; Thrombophlebitis | 1984 |
Prevention of thromboembolic complications with miniheparin-dihydroergotamine in patients undergoing lumbar disc operations.
Topics: Adult; Blood Coagulation Tests; Clinical Trials as Topic; Dihydroergotamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Humans; Intervertebral Disc Displacement; Male; Postoperative Complications; Pulmonary Embolism; Thromboembolism; Thrombophlebitis | 1984 |
[The risk of hemorrhaging in the prevention of thromboembolism in general surgery: comparison of low-dose heparin and heparin-dihydergot 2500].
Topics: Adult; Aged; Dihydroergotamine; Double-Blind Method; Drug Combinations; Female; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Postoperative Complications; Prospective Studies; Random Allocation; Risk; Surgical Procedures, Operative; Thromboembolism | 1983 |
Low-dose heparin: an aid to therapy.
Topics: Aspirin; Clinical Trials as Topic; Dihydroergotamine; Double-Blind Method; Electric Stimulation; Hemorrhage; Heparin; Humans; Postoperative Complications; Prospective Studies; Pulmonary Embolism; Thromboembolism; Thrombophlebitis | 1980 |
Low-dose heparin - present status and future trends.
Topics: Clinical Trials as Topic; Dihydroergotamine; Drug Therapy, Combination; Forecasting; Hemorrhage; Heparin; Humans; Postoperative Complications; Pulmonary Embolism; Thrombophlebitis | 1980 |
[Thromboembolism prophylaxis with reduced bleeding risk. Trials with heparin-dihydroergot 2500].
Topics: Dihydroergotamine; Drug Combinations; Drug Therapy, Combination; Hemorrhage; Heparin; Humans; Postoperative Complications; Thromboembolism | 1981 |
Regression of deep vein thrombosis by i.v.-administration of a low molecular weight heparin--results of a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Dihydroergotamine; Drug Combinations; Factor Xa Inhibitors; Female; Hematuria; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Infusions, Intravenous; Male; Middle Aged; Partial Thromboplastin Time; Pilot Projects; Thrombophlebitis; Tissue Plasminogen Activator; Treatment Outcome | 1994 |
Prevention of deep vein thrombosis in neurosurgical patients: a prospective double-blind comparison of two prophylactic regimen.
Topics: Adult; Aged; Dihydroergotamine; Double-Blind Method; Drug Combinations; Female; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Humans; Intervertebral Disc Displacement; Lumbar Vertebrae; Male; Middle Aged; Postoperative Complications; Prospective Studies; Risk Factors; Thrombophlebitis | 1992 |
Apparent lack of synergism between heparin and dihydroergotamine in prevention of deep vein thrombosis after elective hip replacement: a randomised double-blind trial reported in conjunction with an overview of previous results.
Topics: Aged; Dihydroergotamine; Double-Blind Method; Drug Synergism; Female; Hemorrhage; Heparin; Hip Prosthesis; Humans; Male; Middle Aged; Prospective Studies; Thrombophlebitis | 1992 |
[Different effectiveness of two preparations of low molecular weight heparin in patients with elective hip joint replacement].
Topics: Adult; Aged; Aged, 80 and over; Blood Loss, Surgical; Dihydroergotamine; Drug Combinations; Female; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Hip Prosthesis; Humans; Male; Middle Aged; Postoperative Complications; Prospective Studies; Pulmonary Embolism; Radionuclide Imaging; Risk Factors; Thrombophlebitis | 1991 |
Prevention of deep vein thrombosis by low-molecular-weight heparin and dihydroergotamine in patients undergoing total hip replacement.
Topics: Adult; Aged; Aged, 80 and over; Dihydroergotamine; Double-Blind Method; Drug Administration Schedule; Female; Hemorrhage; Heparin, Low-Molecular-Weight; Hip Prosthesis; Humans; Injections, Subcutaneous; Male; Middle Aged; Thrombolytic Therapy; Thrombophlebitis | 1991 |
[Perioperative prevention of thromboembolism with low molecular weight heparin and postoperative bleeding complications].
Topics: Dihydroergotamine; Double-Blind Method; Drug Therapy, Combination; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Humans; Postoperative Complications; Prospective Studies; Pulmonary Embolism; Risk Factors; Thromboembolism; Thrombophlebitis | 1990 |
[Prevention of thromboembolism in para-articular femoral fractures of the hip--results of a prospective randomized study of heparin-DHE and ASS-DHE].
Topics: Aged; Aged, 80 and over; Aspirin; Bone Screws; Cause of Death; Dihydroergotamine; Drug Combinations; Female; Fracture Fixation, Internal; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Hip Fractures; Hip Prosthesis; Humans; Male; Middle Aged; Postoperative Complications; Prospective Studies; Pulmonary Embolism; Randomized Controlled Trials as Topic; Thromboembolism | 1990 |
A prospective randomized trial of low molecular weight heparin-DHE and conventional heparin-DHE (with acenocoumarol) in patients undergoing gynaecological surgery.
Topics: Acenocoumarol; Clinical Trials as Topic; Dihydroergotamine; Drug Combinations; Female; Genital Diseases, Female; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Humans; Hysterectomy; Postoperative Complications; Premedication; Prospective Studies; Pulmonary Embolism; Random Allocation; Thrombophlebitis | 1989 |
Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial.
Topics: Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Dihydroergotamine; Double-Blind Method; Drug Combinations; Female; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Hip Prosthesis; Humans; Male; Middle Aged; Postoperative Complications; Prospective Studies; Random Allocation; Thrombophlebitis | 1988 |
[Effectiveness and side effects of low-molecular weight heparin-dihydroergotamine in preventing thromboembolism in abdominal surgery].
Topics: Abdomen; Adult; Aged; Aged, 80 and over; Blood Coagulation Tests; Clinical Trials as Topic; Dihydroergotamine; Double-Blind Method; Drug Combinations; Female; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Molecular Weight; Postoperative Complications; Pulmonary Embolism; Risk; Thrombophlebitis | 1986 |
Bleeding after hip arthroplasty not increased by heparin plus dihydroergotamine.
Topics: Adult; Aged; Aged, 80 and over; Dihydroergotamine; Double-Blind Method; Female; Hemorrhage; Heparin; Hip Prosthesis; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Thrombophlebitis | 1987 |
5 other study(ies) available for dihydroergotamine and Bleeding
Article | Year |
---|---|
[Use of heparin in combination with dihydroergotamine for the postoperative prevention of thrombosis in general surgery].
Topics: Cheek; Dihydroergotamine; Drug Therapy, Combination; Hemorrhage; Heparin; Humans; Injections; Injections, Subcutaneous; Postoperative Complications; Surgical Procedures, Operative; Thromboembolism | 1984 |
Plasma concentrations of noradrenaline and adrenaline and plasma renin activity during extradural blockade in dogs.
Topics: Anesthesia, Epidural; Animals; Blood Pressure; Dihydroergotamine; Dogs; Epinephrine; Female; Heart Rate; Hemorrhage; Lidocaine; Male; Norepinephrine; Renin; Time Factors | 1980 |
Comparison of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin, with or without dihydroergotamine, in abdominal hysterectomy.
Topics: Dihydroergotamine; Female; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Humans; Hysterectomy; Postoperative Complications; Pulmonary Embolism; Thrombophlebitis | 1992 |
[Complications of thromboembolic prophylaxis with heparin-dihydroergotamine].
Topics: Adult; Aged; Coronary Disease; Dihydroergotamine; Drug Therapy, Combination; Female; Hemorrhage; Heparin; Humans; Intervertebral Disc Displacement; Male; Prospective Studies | 1989 |
The use of dihydroergotamine and heparin in the prophylaxis of deep venous thrombosis.
Topics: Dihydroergotamine; Drug Therapy, Combination; Hemorrhage; Heparin; Hip Prosthesis; Humans; Knee Prosthesis; Postoperative Complications; Spasm; Thrombocytopenia; Thrombophlebitis; Vascular Diseases | 1986 |